Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome.
10.3904/kjim.2014.29.6.827
- Author:
Rajshekhar CHAKRABORTY
1
;
Shiva Kumar Reddy MUKKAMALLA
;
Kranthi SINGAM
;
Natalia CALDERON
Author Information
1. Department of Internal Medicine, Queens Hospital Center, Icahn School of Medicine at Mount Sinai, Jamaica, NY, USA. rajshekhar.ucms@gmail.com
- Publication Type:Letter ; Case Reports
- MeSH:
Adult;
Antineoplastic Agents/therapeutic use;
*Chromosome Deletion;
*Chromosomes, Human, Pair 9;
Cytogenetic Analysis;
DNA Mutational Analysis;
Fusion Proteins, bcr-abl/*antagonists & inhibitors/genetics/metabolism;
Gene Expression Regulation;
Humans;
Incidental Findings;
Klinefelter Syndrome/complications/diagnosis/*genetics;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications/diagnosis/*drug therapy/enzymology/genetics;
Male;
Molecular Targeted Therapy;
Protein Kinase Inhibitors/*therapeutic use;
Remission Induction;
Time Factors;
Treatment Outcome
- From:The Korean Journal of Internal Medicine
2014;29(6):827-829
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
